Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic
During this uncertain and unprecedented time, the oncofertility community is working together to provide up-to-date fertility preservation information for patients and providers. We are aware of the recommendations from ASRM’s COVID-19 Task Force which suggests new IVF cycles not be initiated at this time. While this pause in services does not apply to urgent fertility preservation for patients